Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Psychostimulant Abuse - Novel Treatment Approaches - 1

This study has been completed.
Sponsor:
Collaborator:
Mclean Hospital
Information provided by:
National Institute on Drug Abuse (NIDA)
ClinicalTrials.gov Identifier:
NCT00000325
First received: September 20, 1999
Last updated: June 23, 2005
Last verified: December 2002
  Purpose

To determine if acute assessments of profasi and factrel affect plasma cocaine levels and cocaine-induced behavioral changes in men.


Condition Intervention Phase
Cocaine-Related Disorders
Behavioral: Gonadorelin
Phase 1

Study Type: Interventional
Study Design: Primary Purpose: Treatment
Official Title: Psychostimulant Abuse - Novel Treatment Approaches

Resource links provided by NLM:


Further study details as provided by National Institute on Drug Abuse (NIDA):

Estimated Enrollment: 0
Estimated Study Completion Date: December 2001
  Eligibility

Genders Eligible for Study:   Male
Accepts Healthy Volunteers:   No
Criteria

Please contact site for information.

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00000325

Locations
United States, Massachusetts
McLean Hospital, Dept. of Psychiatry
Belmont, Massachusetts, United States, 2178
Sponsors and Collaborators
Mclean Hospital
Investigators
Principal Investigator: Jack Mendelson, M.D. Mclean Hospital
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00000325     History of Changes
Other Study ID Numbers: NIDA-10757-1, R01-10757-1
Study First Received: September 20, 1999
Last Updated: June 23, 2005
Health Authority: United States: Federal Government

Additional relevant MeSH terms:
Cocaine-Related Disorders
Chemically-Induced Disorders
Mental Disorders
Substance-Related Disorders

ClinicalTrials.gov processed this record on November 27, 2014